Heat Biologics, Inc. (HTBX) Social Stream



Heat Biologics, Inc. (HTBX): $2.38

0.01 (+0.42%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add HTBX to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#184 of 395

in industry

Featured Post From StockTwits About HTBX

$HTBX Heat Biologics Corporate Milestones for 2021:
✅William Ostrander appointed CFO - January 2021 ✅Various coronavirus vaccine milestones – 2021
o Began manufacturing process for ZVX-60 - January 2021 o Investigational New Drug (IND) Application
o Phase I launch
✅Positive interim survival data from HS-110 Ph2 NSCLC - February 2021 ✅Discussion with potential partners – ongoing
✅Complete HS-130 Phase I trial – 1H:21
✅Complete PTX-35 Phase I trial – 1H:21
✅Data readout at ASCO for HS-110 – June 2021 ✅ End of Phase II meeting for HS-110 – 2021
✅Data readout on Phase I HS-130 – 2H:21
✅Data readout on Phase I PTX-35 – 2H:21
✅Additional detail regarding Phase III target NSCLC settings for HS-110
Tradelike1, published August 16, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!